#Canada #Toronto #Vaccine Production #Recombinant Insulin #Trypsin

Webinar Overview

Join us for a comprehensive and informative webinar titled "Using Recombinant Insulin and Trypsin for Safer Vaccine Production." This event, hosted by Xtalks, is set to take place on Thursday, January 29, 2026, at 10 AM EST (4 PM CET). The webinar is designed to shed light on the cutting-edge advancements in vaccine production that utilize recombinant insulin and trypsin. Attendees can expect to gain valuable insights into how these components improve both safety and efficiency in the manufacturing process of cell-based vaccines.

Importance of Safe Vaccine Production

The world is continuously faced with the challenge of vaccine production that is not only efficient but also safe. Considering the demands for higher safety standards, the vaccination process must incorporate strategies that prevent contamination and ensure high-quality outcomes. Recent advancements in biomanufacturing have established animal-free reagents as the gold standard. This shift addresses critical needs for enhanced consistency and reduced contamination risks associated with traditional methods.

Key Topics of Discussion

During the webinar, our distinguished speakers from Novo Nordisk Pharmatech A/S will discuss:

• - Recombinant Insulin: Its role in improving viral production across various vaccine platforms. Attendees will learn how insulin enhances cell culture performance and supports consistent production in Vero and HEK293 cell systems.
• - Recombinant Trypsin: This reagent addresses safety concerns against animal-derived trypsin traditionally used in cell dissociation and virus production. It boosts virus infectivity and quality while mitigating contamination risks.
• - Implementation Strategies: How the efficient application of both insulin and trypsin can translate to cost-effective and reliable vaccine production methods.

Insights from Industry Experts

The speakers for this session include:

• - Dr. Sara Bursomanno, Senior Global Product Manager, who will provide a detailed examination of the latest research and applications of recombinant insulin in the industry.
• - Chantale Julien, MSc, Global Product Manager, who will elaborate on the advancements in trypsin technology and its implications for vaccine safety.

Register for the Webinar

Do not miss the opportunity to join experts and peers in discussing these pivotal advancements in vaccine production. Gain insight that can be crucial for keeping up with innovations in the pharmaceutical and biotechnological sectors. Register today to secure your spot and ensure you stay informed about these critical developments in vaccine production technology.

For more information and to register for the webinar, please visit the link: Using Recombinant Insulin and Trypsin for Safer Vaccine Production.

About Xtalks

Xtalks is a renowned provider of educational webinars and digital content aimed at the life science, healthcare, and medical device industry. Each year, thousands of professionals turn to Xtalks for information on the latest trends, regulations, and developments in these fields. The platform serves as a valuable resource for keeping industry practitioners abreast of essential knowledge in their respective domains.

Explore how recombinant insulin and trypsin can transform your approach to vaccine production and enhance safety and efficiency in your practices. We look forward to seeing you there!